Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 22 member 8 (SLC22A8), commonly known as Organic Anion Transporter 3 (OAT3), is a multispecific transmembrane transporter primarily localized to the basolateral membrane of renal proximal tubule cells. It functions as an organic anion/dicarboxylate exchanger, coupling the uptake of organic anions from the blood into renal cells with the efflux of intracellular dicarboxylates like alpha-ketoglutarate. This transport mechanism is critical for the renal secretion and systemic clearance of a wide variety of endogenous metabolites, including uremic toxins, urate, and conjugated steroid hormones, as well as numerous clinically important drugs.
In disease states, altered expression or genetic polymorphisms of SLC22A8 are associated with chronic kidney disease, hyperuricemia, gout, and drug-induced nephrotoxicity. Because OAT3 handles a significant portion of commonly prescribed medications—such as antibiotics, NSAIDs, statins, and antivirals—it is a major mediator of clinically significant drug-drug interactions (DDIs). Consequently, regulatory agencies like the FDA and EMA recommend evaluating new molecular entities for their interaction with OAT3 to predict renal safety and optimize dosing regimens.
Inhibition of organic anion transport or substrate-mediated renal clearance
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 22 member 8 (OAT3).